Inventor · disambiguated record
Andrew Kolodziej
Also filed as: KOLODZIEJ ANDREW · KOLODZIEJ ANDREW F
15 granted patents·10 pending applications·170 citations·filing 2000–2024
93Inventor score
Files withFLATLEY DISCOVERY LAB LLC7EPIX PHARM INC4CARDONE MICHAEL H2EPIX MEDICAL INC A DELAWARE CO2EUTROPICS PHARMACEUTICALS INC2
Top patents by PatentIndex Score
25 records- 0195US9855249B2Isoxazole compounds and methods for the treatment of cystic fibrosisFLATLEY DISCOVERY LAB LLC·Filed 2015·Granted Jan 2, 2018·13 cites·16 claims
- 0294US6652835B1Targeting multimeric imaging agents through multilocus bindingEPIX MEDICAL INC·Filed 2000·Granted Nov 25, 2003·64 cites·15 claims
- 0388US8987271B22,2′-biphenazine compounds and methods useful for treating diseaseCARDONE MICHAEL H·Filed 2011·Granted Mar 24, 2015·12 cites·6 claims
- 0487US7238341B2Peptide-based multimeric targeted contrast agentsEPIX PHARM INC·Filed 2004·Granted Jul 3, 2007·18 cites·7 claims
- 0586US6991775B2Peptide-based multimeric targeted contrast agentsEPIX PHARM INC·Filed 2002·Granted Jan 31, 2006·24 cites·17 claims
- 0683US9051305B2Compositions and methods useful for treating diseasesCARDONE MICHAEL H·Filed 2012·Granted Jun 9, 2015·3 cites·23 claims
- 0783US7186797B2Polypeptide conjugates with extended circulating half-livesEPIX PHARM INC·Filed 2002·Granted Mar 6, 2007·14 cites·44 claims
- 0881US9790215B2Pyridazinone compounds and methods for the treatment of cystic fibrosisFLATLEY DISCOVERY LAB LLC·Filed 2014·Granted Oct 17, 2017·3 cites·10 claims
- 0981US9783529B2Pyridazinone compounds and methods for the treatment of cystic fibrosisFLATLEY DISCOVERY LAB LLC·Filed 2014·Granted Oct 10, 2017·3 cites·14 claims
- 1080US9345700B2Compositions and methods useful for treating diseasesEUTROPICS PHARMACEUTICALS INC·Filed 2015·Granted May 24, 2016·2 cites·19 claims
- 1179US9351971B2Substituted 2,2′-biphenazines for treating diseasesEUTROPICS PHARMACEUTICALS INC·Filed 2015·Granted May 31, 2016·3 cites·20 claims
- 1277US10370366B2Pyridazinone compounds and methods for the treatment of cystic fibrosisFLATLEY DISCOVERY LAB LLC·Filed 2017·Granted Aug 6, 2019·1 cites·11 claims
- 1376US7927581B2Peptide-based multimeric targeted contrast agentsFACTOR 1A LLC·Filed 2005·Granted Apr 19, 2011·1 cites·10 claims
- 1468US2020017486A1Pyridazinone compounds and methods for the treatment of cystic fibrosisFLATLEY DISCOVERY LAB LLC·Filed 2019·Application pending·0 cites
- 1567US8034898B2Methods of collagen imagingCOLLAGEN MEDICAL LLC·Filed 2006·Granted Oct 11, 2011·8 cites·17 claims
- 1661US2007185311A1Peptide-Based Multimeric Targeted Contrast AgentsEPIX PHARM INC·Filed 2006·Application pending·0 cites
- 1761US2025195647A1ANTI-alpha-V-beta-8 INTEGRIN ANTIBODIES AND USES THEREOFCORBUS PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 1860US2022402925A1Compounds and methods for the treatment of cystic fibrosisFLATLEY DISCOVERY LAB LLC·Filed 2022·Application pending·0 cites
- 1958US2005201943A1Magnetic resonance imaging using contrast agents bioactivated by enzymatic cleavageEPIX MEDICAL INC A DELAWARE CO·Filed 2005·Application pending·0 cites
- 2056US2004005274A1Targeting multimeric imaging agents through multilocus bindingEPIX MEDICAL INC A DELAWARE CO·Filed 2003·Application pending·0 cites
- 2155US2003082106A1Magnetic resonance imaging using contrast agents bioactivated by enzymatic cleavageFiled 2002·Application pending·0 cites
- 2255US2023055237A1Compounds and methods for the treatment of cystic fibrosisFLATLEY DISCOVERY LAB LLC·Filed 2021·Application pending·0 cites
- 2352US9386938B2Methods for collagen imagingCARAVAN PETER D·Filed 2011·Granted Jul 12, 2016·1 cites·18 claims
- 2451US2007111947A1Fibrin targeted therapeuticsMCMURRY THOMAS J·Filed 2006·Application pending·0 cites
- 2549US2005261472A1Binding moieties for fibrinEPIX MEDICAL INC MASSACHUSETTS·Filed 2003·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Andrew Kolodziej files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →